| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/16/2009 | EP2099443A1 Combination of er + ligands and histone deacetylase inhibitors for the treatment of cancer |
| 09/16/2009 | EP2099442A1 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 09/16/2009 | EP2099441A1 Metal delivery agents and therapeutic uses of the same |
| 09/16/2009 | EP1960371B1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase |
| 09/16/2009 | EP1910383B1 Benzodiazepine derivatives and uses thereof in medical field |
| 09/16/2009 | EP1828184B1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
| 09/16/2009 | EP1651214B1 Benzimidazole derivatives as mek inhibitors |
| 09/16/2009 | EP1581488B1 Inhibitors of tace |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1472541B1 Imaging agents and methods of imaging naaladase of psma |
| 09/16/2009 | EP1438583B1 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1411046B1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1349568B1 Immunomodulatory constructs and their uses |
| 09/16/2009 | EP1223978B9 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 09/16/2009 | EP1169021B1 Compositions and methods for treating lymphoma |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 09/16/2009 | CN101534852A Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 09/16/2009 | CN101532030A Recombinant influenza virus vector carrying foreign genes in NA segment and preparation method and application thereof |
| 09/16/2009 | CN101532027A Hypoxia inducible eukaryotic gene expression vector and application thereof |
| 09/16/2009 | CN101532019A Core fragment of human ZHX2 transcription factor and application thereof |
| 09/16/2009 | CN101531720A Streptavidin/green fluorescent fusion protein |
| 09/16/2009 | CN101531718A Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531707A New antitumoral compounds |
| 09/16/2009 | CN101531706A Tumor vascular targeting peptide GX1 |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101531682A Metal coordination complex and method for preparing same |
| 09/16/2009 | CN101531664A Method for synthesizing a series of camptothecin substituted cinnamate |
| 09/16/2009 | CN101531653A Salts of 3-(4-amino-1-oxo-1,3-dihydro-iso-indol-2-yl)piperdine-2,6-dione and derivatives thereof, polymorph of the salts, preparation and application thereof |
| 09/16/2009 | CN101531652A Novel method for extracting anthocyanin in bilberry by double water phases |
| 09/16/2009 | CN101531645A Synthesis method of Duoxitasai |
| 09/16/2009 | CN101531644A New daphnane diterpene compounds in Daphne genkwa as well as preparation method and application of same |
| 09/16/2009 | CN101531630A Asymmetric chiral double-Schiff base simple synthesizing method |
| 09/16/2009 | CN101531613A Aminopeptidase N inhibitor bestatin dino ester, synthesis and application thereof |
| 09/16/2009 | CN101531590A Ginkgoic acid preparation method using macroporous adsorption resin |
| 09/16/2009 | CN101531570A 1,2,3-substituted-5-acetylenyl-(or 10,11-dihydro)-5H-diphenyl[a,d] suberne (alkyl)-5-alcohol, synthesizing method and application |
| 09/16/2009 | CN101531563A Chemical complexing directional separation and purification method for preparing high-purity beta-elemene raw material medicament |
| 09/16/2009 | CN101530619A Method for preparing water soluble pegylation hydroxycamptothecine derivatives |
| 09/16/2009 | CN101530615A Divalent recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530614A Pentavalent recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530612A Type-16 recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530607A Method for extracting gingerol type material from ginger with high efficiency |
| 09/16/2009 | CN101530606A Chinese medicinal preparation for treating cardiac malignant tumor |
| 09/16/2009 | CN101530605A Chinese medicinal preparation for treating malignant parotid tumors |
| 09/16/2009 | CN101530589A Chinese medicinal preparation for treating cancers |
| 09/16/2009 | CN101530584A Chinese medicinal preparation for treating malignant tumor of nasopharynx |
| 09/16/2009 | CN101530577A Chinese medicinal preparation for treating malignant tumor of mouth floor |
| 09/16/2009 | CN101530575A Nanometer oral preparation and preparation method thereof |
| 09/16/2009 | CN101530573A Chinese medicine for treating tumor |
| 09/16/2009 | CN101530548A Composition with multiple health-care functions and preparation method thereof |
| 09/16/2009 | CN101530542A Oral pharmaceutical preparation of chinaroot greenbrier total aglycon and preparation method and application thereof |
| 09/16/2009 | CN101530541A Chinese traditional medicine for curing advanced lung cancer |
| 09/16/2009 | CN101530539A Chinese medicinal preparation for treating lip cancer |
| 09/16/2009 | CN101530524A Chinese medicinal preparation for treating malignant tumor of esophagus |
| 09/16/2009 | CN101530508A Traditional Chinese medicine for treating ovarian cancer |
| 09/16/2009 | CN101530504A Chinese medicinal preparation for treating malignant tumor of tongue |
| 09/16/2009 | CN101530490A Traditional Chinese medicine for treating bladder cancer |
| 09/16/2009 | CN101530488A Chinese medicinal preparation for treating salivary gland malignant tumor |
| 09/16/2009 | CN101530476A Chinese medicinal preparation for treating malignant tumor of palatum |
| 09/16/2009 | CN101530468A Chinese medicinal preparation for treating gum cancer |
| 09/16/2009 | CN101530464A Alcohol extract of walnut kernel and use thereof |
| 09/16/2009 | CN101530461A Traditional Chinese medicine for treating nasopharyngeal cancer |
| 09/16/2009 | CN101530457A Nanometer ginseng and astragalus strengthening solid preparation and preparation method thereof |
| 09/16/2009 | CN101530440A Oral pharmaceutical preparation of aralia elata total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530436A Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 09/16/2009 | CN101530432A Method for producing degreased concentrated solution of tussah male moth |
| 09/16/2009 | CN101530429A New use of clarias lazera |
| 09/16/2009 | CN101530422A Liquid-phase adenosine triphosphate coupled nanometer simple substance selenium and preparation and storage method thereof |
| 09/16/2009 | CN101530420A Application of tunicamycin in preparing tumour cell reversing drug |
| 09/16/2009 | CN101530411A Application for taking NO donor-type compounds as P-glycoprotein inhibitors and tumor multi-drug resistance reversal agents |
| 09/16/2009 | CN101530408A Antineoplastic medicine composition and application thereof |
| 09/16/2009 | CN101530389A Ginsenoside Rg 3 and phospholipid complex and preparing method thereof |
| 09/16/2009 | CN100541198C Methods for diagnosis and therapy of cancer and composition useful therein |
| 09/16/2009 | CN100540570C Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 09/16/2009 | CN100540559C Lipoid compound regulator and use thereof |
| 09/16/2009 | CN100540548C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540053C New clinical parameters for determining hematologic toxicity proior to radioimmunotherapy |
| 09/16/2009 | CN100540006C Platinum derivative pharmaceutical formulations |
| 09/16/2009 | CN100540001C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 09/15/2009 | US7589181 Humanized anti-TAG-72 CC49 monoclonal antibodies; retain binding affinity for TAG-72 and have reduced immunogenicity, as compared to a parental HuCC49V10 antibody; carcinoma; antitumor agent |
| 09/15/2009 | US7589180 Specific binding proteins and uses thereof |
| 09/15/2009 | US7589099 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor; |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7589086 Substituted pyrazolo[3,4-D]pyrimidines as anti-tumor agents |
| 09/15/2009 | US7589084 Anticancer compositions, and methods of making and using the same |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7588930 Fusing to the antigen a Listerial truncated ActA protein; listeria vaccine strain |
| 09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2464289C Heterocyclic retinoid compounds |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2440650C Photosensitizer and method for production thereof |
| 09/15/2009 | CA2439879C C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |